Capital Impact Advisors, LLC Global Blood Therapeutics, Inc. Transaction History

Capital Impact Advisors, LLC

  • $3.16 Billion
  • Q3 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$22.3 - $37.39 $107,798 - $180,743
-4,834 Reduced 16.67%
24,167 $772,000
Q1 2022

May 16, 2022
BUY
$25.68 - $35.59 $167,947 - $232,758
6,540 Added 29.12%
29,001 $1.01 Million
Q4 2021

Feb 14, 2022
BUY
$24.9 - $40.26 $559,278 - $904,279
22,461 New
22,461 $657,000
Q4 2020

Feb 12, 2021
SELL
$37.65 - $63.77 $992,529 - $1.68 Million
-26,362 Closed
0 $0
Q3 2020

Nov 13, 2020
SELL
$52.76 - $74.49 $263,800 - $372,450
-5,000 Reduced 15.94%
26,362 $1.45 Million
Q2 2020

Aug 17, 2020
SELL
$48.73 - $81.82 $890,199 - $1.49 Million
-18,268 Reduced 36.81%
31,362 $1.98 Million
Q1 2020

May 15, 2020
BUY
$41.72 - $87.2 $61,537 - $128,620
1,475 Added 3.06%
49,630 $2.54 Million
Q3 2019

Nov 14, 2019
BUY
$45.35 - $57.91 $375,906 - $480,015
8,289 Added 20.79%
48,155 $2.37 Million
Q2 2019

Jul 19, 2019
SELL
$52.6 - $63.29 $614,683 - $739,606
-11,686 Reduced 22.67%
39,866 $2.15 Million
Q3 2018

Oct 19, 2018
BUY
$38.0 - $51.1 $114,646 - $154,168
3,017 Added 6.22%
51,552 $1.97 Million
Q2 2018

Jul 25, 2018
BUY
$38.7 - $50.15 $733,984 - $951,144
18,966 Added 64.14%
48,535 $2.3 Million
Q1 2018

Apr 11, 2018
BUY
$39.6 - $65.9 $1.17 Million - $1.95 Million
29,569 New
29,569 $1.43 Million

Others Institutions Holding GBT

# of Institutions
8
Shares Held
288K
Call Options Held
0
Put Options Held
0
View Full List

About Global Blood Therapeutics, Inc.

GBT Quotes by TradingView
  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Capital Impact Advisors, LLC Portfolio

Follow Capital Impact Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Impact Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Impact Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email